XML 49 R36.htm IDEA: XBRL DOCUMENT
v3.24.4

Common Stock, Stock Options and Warrants (Details) - Schedule of Determining the fair Value of Stock Option Grants | Sep. 30, 2024 | Sep. 30, 2023
--- | --- | ---
Risk-free interest rate [Member] | Minimum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 4.62 | 1.05
Risk-free interest rate [Member] | Minimum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 4.66 | 4.11
Risk-free interest rate [Member] | Maximum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 4.66 | 2.94
Risk-free interest rate [Member] | Maximum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 4.66 | 4.11
Expected dividend yield [Member] | Minimum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 0 | 0
Expected dividend yield [Member] | Minimum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 0 | 0
Expected dividend yield [Member] | Maximum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 0 | 0
Expected dividend yield [Member] | Maximum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 0 | 0
Expected term [Member] | Minimum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 5.5 | 6.5
Expected term [Member] | Minimum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 6.5 | 5.96
Expected term [Member] | Maximum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 10 | 10
Expected term [Member] | Maximum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 6.5 | 5.96
Expected volatility [Member] | Minimum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 85 | 94
Expected volatility [Member] | Minimum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 87 | 91
Expected volatility [Member] | Maximum [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 86 | 110
Expected volatility [Member] | Maximum [Member] | Citius Oncology [Member] |  |
Schedule of Determining the fair Value of Stock Option Grants [Line Items] |  |
fair value of stock option grants | 87 | 91

X
- Definition Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_EquitySecuritiesFvNiMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ValuationAllowanceLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ctxr_CitiusOncologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |